Division of Laryngology, USC Caruso Department of Otolaryngology-Head and Neck Surgery, Keck School of Medicine of USC, Los Angeles, California.
JAMA Otolaryngol Head Neck Surg. 2018 Mar 1;144(3):203-210. doi: 10.1001/jamaoto.2017.2800.
Endoscopic dilation is the mainstay treatment strategy for subglottic and proximal tracheal stenosis (SGS/PTS). Its major limitation is restenosis requiring repeated surgery. Intralesional steroid injection (ISI) is a promising adjunctive treatment aimed at prolonging the effects of dilation.
To evaluate the association of serial in-office ISI after endoscopic dilation with surgery-free interval (SFI) in adults with SGS/PTS.
DESIGN, SETTING, AND PARTICIPANTS: A retrospective study of adults with SGS/PTS who underwent at least 2 consecutive in-office ISI at the University of Southern California, Keck School of Medicine, over a 3-year period was conducted.
Serial ISI with triamcinolone 40 mg/mL using topical anesthesia, spaced 3 to 6 weeks apart.
Surgery-free interval, number of dilations, need for open airway surgery, decannulation rate, and adverse events. Patients with previous dilations and sufficient follow-up time were included in a comparative analysis of SFI before and after ISI. The Mann-Whitney U test was applied for comparisons.
Twenty-four patients met eligibility criteria. Mean (SD) age was 50.1 (15.1) years; 18 (75%) were female. Ten (42%) patients had idiopathic, 8 (33%) had traumatic, and 6 (25%) had rheumatologic-related SGS/PTS. Mean (SD) follow-up time was 32.3 (33.4) months. Patients underwent mean (SD) 4.08 (1.91) injections. Seventeen (71%) patients have not undergone further surgery after ISI. Mean (SD) SFI was 17.8 (12.8) months overall and was 15.7 (10.6) months for idiopathic, 13.8 (9.9) for traumatic, and 26.7 (16.9) for rheumatologic-related SGS/PTS. Twenty-one (88%) patients underwent dilation(s) prior to ISI. Among patients who fulfilled eligibility criteria for comparison of SFI before and after ISI, SFI improved from 10.1 months before, to 22.6 months after ISI (mean difference, 12.5 months; 95% CI, -2.1 to 27.2 months). Three of 6 patients (all with traumatic SGS/PTS) presenting with a tracheotomy were decannulated. No patients required open airway surgery after ISI. There were no adverse events associated with ISI.
Serial in-office ISI are safe and well-tolerated in adults with SGS/PTS. This technique can reduce the surgical burden on these patients and may obviate the need for future airway intervention.
内镜扩张是治疗声门下和近段气管狭窄(SGS/PTS)的主要治疗策略。其主要局限性是再狭窄,需要反复手术。腔内类固醇注射(ISI)是一种有前途的辅助治疗方法,旨在延长扩张的效果。
评估成人 SGS/PTS 患者内镜扩张后连续门诊 ISI 与无手术间隔(SFI)的相关性。
设计、地点和参与者:这项在南加州大学凯克医学院进行的回顾性研究纳入了至少连续 2 次在门诊接受 ISI 的成人 SGS/PTS 患者,研究时间为 3 年。
使用局部麻醉剂每隔 3 至 6 周注射曲安奈德 40mg/ml 的连续 ISI。
无手术间隔、扩张次数、需要开放性气道手术、拔管率和不良事件。对接受过先前扩张且随访时间足够的患者进行了 ISI 前后 SFI 的比较分析。应用 Mann-Whitney U 检验进行比较。
24 名患者符合入选标准。平均(SD)年龄为 50.1(15.1)岁;18 名(75%)为女性。10 名(42%)患者为特发性、8 名(33%)为创伤性、6 名(25%)为风湿性 SGS/PTS。平均(SD)随访时间为 32.3(33.4)个月。患者平均(SD)接受 4.08(1.91)次注射。17 名(71%)患者在 ISI 后未再进行手术。总体 SFI 平均(SD)为 17.8(12.8)个月,特发性为 15.7(10.6)个月,创伤性为 13.8(9.9)个月,风湿性为 26.7(16.9)个月。21 名(88%)患者在接受 ISI 之前接受了扩张术。在符合 ISI 前后 SFI 比较入选标准的患者中,SFI 从 ISI 前的 10.1 个月改善至 ISI 后的 22.6 个月(平均差异为 12.5 个月;95%CI 为-2.1 至 27.2 个月)。6 名(均为创伤性 SGS/PTS)接受气管切开术的患者中有 3 名拔管。ISI 后无患者需要进行开放性气道手术。ISI 无不良事件。
在成人 SGS/PTS 患者中,连续门诊 ISI 是安全且耐受良好的。该技术可减轻患者的手术负担,并可能避免未来气道干预的需要。